Heart failure & cardiomyopathiesSecondary analysis

Obesity in Heart Failure with Preserved Ejection Fraction: Insights from the REDUCE LAP-HF II Trial

Eur J Heart FailPublished

  • Secondary analysis of the REDUCE LAP-HF II randomised trial

Authors' conclusion

Increasing severity of obesity was associated with greater cardiac remodelling, higher right and left ventricular filling pressures, higher cardiac output and increased subsequent heart failure events.

Study context

Population
Patients with heart failure with preserved ejection fraction (HFpEF) (EF ≥40%, exercise pulmonary capillary wedge pressure (PCWP) ≥25 mmHg) randomised to atrial shunt or sham procedure
Participants
626 patients
Comparison
Severity of obesity
Primary endpoint
Relationship between severity of obesity and clinical, echocardiographic and haemodynamic parameters

Primary result

As reported in the abstract

Patients with body mass index (BMI) ≥30 kg/m²

60.9%

Further findings

HF events

Obesity associated with more first and recurrent HF events

Atrial shunt treatment effect by obesity

No significant interaction between obesity and treatment effects of the atrial shunt

Original publication

Obesity in Heart Failure with Preserved Ejection Fraction: Insights from the REDUCE LAP-HF II Trial. Eur J Heart Fail. Published 7 December 2023. doi:10.1002/ejhf.3092

Summarised from the published abstract; every number is checked against it